Reported 8 months ago
Novo Nordisk plans to invest $4.1 billion in building a manufacturing facility in Clayton, North Carolina for its GLP-1 weight-loss drugs, Wegovy and Ozempic, doubling the production capacity in the US. This investment coincides with Eli Lilly's unveiling of a new factory in Concord, NC. Senator Bernie Sanders is set to testify on September 24th regarding drug pricing disparities between the US and other countries.
Source: YAHOO